Xilio Therapeutics
28 hedge funds and large institutions have $42.8M invested in Xilio Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 29 → 28 (-1)
11% less capital invested
Capital invested by funds: $48.3M → $42.8M (-$5.49M)
Holders
28
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$627K | |
| 2 | +$92.5K | |
| 3 | +$50.5K | |
| 4 |
Renaissance Technologies
New York
|
+$23.2K |
| 5 |
BlackRock
New York
|
+$8.29K |
Top Sellers
| 1 | -$840K | |
| 2 | -$610K | |
| 3 | -$38K | |
| 4 |
RC
RBF Capital
San Francisco,
California
|
-$29K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.17K |